Abeona Therapeutics Inc vs Acadia Healthcare Company Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Acadia Healthcare Company Inc trades at $31.35 (market cap $2.90B). The key difference: Acadia Healthcare Company Inc is far larger — about 6.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Acadia Healthcare Company Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ACHC | |
|---|---|---|
Market Cap | $421.19M | $2.90B |
Sector | Health | Health |
52-Week High | $7.45 | $35.61 |
52-Week Low | $4.17 | $11.68 |
Enterprise Value | $276.10M | $5.29B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →